Author: Brittney Wheeler

Washington University School of Medicine in St. Louis faculty members David M. Holtzman, MD, and Xiaoying Chen were awarded the inaugural Jeffrey L. Morby Prize from the Cure Alzheimer’s Fund.

Washington University in St. Louis has been chosen to mentor the University of Missouri as part of the U.S. National Science Foundation’s Accelerating Research Translation program.

Researchers at the School of Medicine have identified a novel enzyme involved in building the cell wall of Cryptococcus neoformans, a fungus that causes lung infections and potentially deadly cases of meningitis, primarily in people with AIDS.

Researchers at Washington University School of Medicine in St. Louis, with collaborators at the University of Florida and Stanford University, identified a compound that, in mice, makes naloxone much more effective at counteracting a drug overdose.

Brian A. Gordon, an assistant professor of radiology at the School of Medicine, has received an award from the National Alzheimer’s Coordinating Center and the Alzheimer’s Association to study how adverse events in childhood affect the risk of Alzheimer’s disease.

Washington University School of Medicine in St. Louis has formed a Center for Translational Bioinformatics. The center aims to accelerate research that can improve patient care by integrating comprehensive patient data and expansive genomic datasets.

Chris Anderson, grounds manager and horticulturalist at Washington University in St. Louis, is the recipient of this year’s Gloria W. White Distinguished Service Award.

Medical students at Washington University School of Medicine in St. Louis recently honored faculty and residents with Distinguished Service and Teaching Awards (DSTAs) for the 2023-24 academic year.

Yao Chen, an assistant professor of neuroscience at the School of Medicine, is part of two teams that have been awarded grants to study the molecular processes that underlie memory and cognition.

A study by researchers at Washington University School of Medicine in St. Louis shows that people with COVID-19 who used cannabis were more likely to be hospitalized and require intensive care than those who did not use the drug.